Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial | Zendy

AI Assistant Blog Pricing

Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.